Nectar Lifesciences Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
NECLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nectar Lifesciences has submitted a disclosure to the stock exchange under Regulation 31(4) of the SEBI Takeover Regulations. This regulation applies when the combined shareholding of the promoter and promoter group falls below 50% due to encumbrance (such as pledging or invocation of shares). The filing is a mandatory disclosure and does not, by itself, specify the exact post-encumbrance shareholding or the quantum of shares involved.
For shareholders, this signals that promoter holdings may have dropped under the 50% mark due to pledged or encumbered shares, which can raise concerns about promoter financial health or control of the company. Investors should look for the detailed disclosure on BSE/NSE to understand the exact percentage and reason.